Refocusing the war on cancer: the critical role of personalized treatment.
Level V
Where this comes from
- Record sourced from PubMed, PMID 20410527.
- Also identified by DOI 10.1126/scitranslmed.3000643.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Despite very substantial investment and effort over the past 30 years, the overall survival rate of cancer patients has changed little. We propose that without a truly robust mechanism for selecting the right treatment for the right patient at the right time-the central concepts of personalized medicine-we will continue to see only incremental improvements and have little hope for substantial survival gains. We suggest that it is now imperative that future clinical trials be designed with a plan to incorporate biomarker development.
Medical subject headings
- Neoplasms
- Precision Medicine